StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Internal R&D Expense by Quarter

Internal R&D Expense ($M) ($M)

QuarterlyAnnual

BeOne Medicines Internal R&D Expense: $365M in Q2 2026, up 15.6% from a year earlier. That is the highest of the 33 quarters on record here.

Latest, Q2 2026
365
Period ended Jun 30, 2026
Change on a year earlier
+15.6%
315 in Q2 2025
History
33 quarters
Since Q1 2017
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Internal research and development expenses | 364,658 | 315,390 | 49,268 | 15.6 | %”

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A R&D Expense Summary Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInternal R&D Expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026365+15.6%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026354+21.5%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 2025361+14.7%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 30, 2025320-1.6%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 2025315+6.7%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 2025291+0.6%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 2024315+11.9%Form 10-K (filed 2025-02-27) ↗
Q3 2024Sep 30, 2024325+9.8%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 2024296+2.8%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024289+10.3%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 2023281+7.4%Form 10-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 2023296+17.4%Form 10-Q (filed 2023-11-09) ↗
Q2 2023Jun 30, 2023288+16.1%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 2023262+8.5%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 2022262+14.4%Form 10-K (filed 2023-02-27) ↗
Q3 2022Sep 30, 2022252+23.0%Form 10-Q (filed 2022-11-09) ↗

Cite this data

StockData. (2026). BeOne Medicines Internal R&D Expense ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rd-internal

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.